Logo image of NSPR

INSPIREMD INC (NSPR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NSPR - US45779A8466 - Common Stock

1.93 USD
+0.23 (+13.53%)
Last: 11/21/2025, 8:00:02 PM
2.05 USD
+0.12 (+6.22%)
After Hours: 11/21/2025, 8:00:02 PM
Fundamental Rating

3

NSPR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of NSPR is average, but there are quite some concerns on its profitability. NSPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

NSPR had negative earnings in the past year.
In the past year NSPR has reported a negative cash flow from operations.
In the past 5 years NSPR always reported negative net income.
NSPR had a negative operating cash flow in each of the past 5 years.
NSPR Yearly Net Income VS EBIT VS OCF VS FCFNSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

NSPR has a worse Return On Assets (-124.11%) than 81.38% of its industry peers.
NSPR has a Return On Equity of -204.42%. This is in the lower half of the industry: NSPR underperforms 72.87% of its industry peers.
Industry RankSector Rank
ROA -124.11%
ROE -204.42%
ROIC N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
NSPR Yearly ROA, ROE, ROICNSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600 800

1.3 Margins

NSPR has a Gross Margin of 21.06%. This is in the lower half of the industry: NSPR underperforms 79.26% of its industry peers.
NSPR's Gross Margin has been stable in the last couple of years.
NSPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
NSPR Yearly Profit, Operating, Gross MarginsNSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

6

2. Health

2.1 Basic Checks

NSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
NSPR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NSPR has more shares outstanding
There is no outstanding debt for NSPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NSPR Yearly Shares OutstandingNSPR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NSPR Yearly Total Debt VS Total AssetsNSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -11.36, we must say that NSPR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NSPR (-11.36) is worse than 79.79% of its industry peers.
There is no outstanding debt for NSPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.36
ROIC/WACCN/A
WACC8.7%
NSPR Yearly LT Debt VS Equity VS FCFNSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

NSPR has a Current Ratio of 2.81. This indicates that NSPR is financially healthy and has no problem in meeting its short term obligations.
NSPR has a Current ratio (2.81) which is in line with its industry peers.
A Quick Ratio of 2.47 indicates that NSPR has no problem at all paying its short term obligations.
NSPR has a Quick ratio (2.47) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 2.47
NSPR Yearly Current Assets VS Current LiabilitesNSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. Growth

3.1 Past

NSPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.00%.
NSPR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.04%.
NSPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.51% yearly.
EPS 1Y (TTM)-12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.25%
Revenue 1Y (TTM)14.04%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%39.39%

3.2 Future

The Earnings Per Share is expected to grow by 8.60% on average over the next years. This is quite good.
The Revenue is expected to grow by 74.86% on average over the next years. This is a very strong growth
EPS Next Y-12.46%
EPS Next 2Y1.92%
EPS Next 3Y8.6%
EPS Next 5YN/A
Revenue Next Year7.09%
Revenue Next 2Y47.95%
Revenue Next 3Y74.86%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NSPR Yearly Revenue VS EstimatesNSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
NSPR Yearly EPS VS EstimatesNSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1M -2M -3M -4M -5M

0

4. Valuation

4.1 Price/Earnings Ratio

NSPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NSPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NSPR Price Earnings VS Forward Price EarningsNSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NSPR Per share dataNSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.92%
EPS Next 3Y8.6%

0

5. Dividend

5.1 Amount

No dividends for NSPR!.
Industry RankSector Rank
Dividend Yield N/A

INSPIREMD INC

NASDAQ:NSPR (11/21/2025, 8:00:02 PM)

After market: 2.05 +0.12 (+6.22%)

1.93

+0.23 (+13.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)03-10 2026-03-10/amc
Inst Owners35.44%
Inst Owner Change-99.26%
Ins Owners14.39%
Ins Owner Change1.52%
Market Cap80.52M
Revenue(TTM)7.78M
Net Income(TTM)-41.38M
Analysts82.5
Price Target4.59 (137.82%)
Short Float %0.39%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.94%
Min EPS beat(2)-7.84%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)5.04%
Min EPS beat(4)-7.84%
Max EPS beat(4)21.57%
EPS beat(8)5
Avg EPS beat(8)-0.74%
EPS beat(12)9
Avg EPS beat(12)7.61%
EPS beat(16)13
Avg EPS beat(16)13.26%
Revenue beat(2)2
Avg Revenue beat(2)9.05%
Min Revenue beat(2)3.38%
Max Revenue beat(2)14.71%
Revenue beat(4)4
Avg Revenue beat(4)6.31%
Min Revenue beat(4)1.97%
Max Revenue beat(4)14.71%
Revenue beat(8)7
Avg Revenue beat(8)4.9%
Revenue beat(12)11
Avg Revenue beat(12)5.53%
Revenue beat(16)13
Avg Revenue beat(16)4.09%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.4
P/FCF N/A
P/OCF N/A
P/B 3.98
P/tB 3.98
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0.17
BVpS0.49
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -124.11%
ROE -204.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.06%
FCFM N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 483.19%
Cap/Sales 23.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.81
Quick Ratio 2.47
Altman-Z -11.36
F-Score3
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)304.1%
Cap/Depr(5y)236.96%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.25%
EPS Next Y-12.46%
EPS Next 2Y1.92%
EPS Next 3Y8.6%
EPS Next 5YN/A
Revenue 1Y (TTM)14.04%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%39.39%
Revenue Next Year7.09%
Revenue Next 2Y47.95%
Revenue Next 3Y74.86%
Revenue Next 5YN/A
EBIT growth 1Y-56.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-33.93%
EBIT Next 3Y-16.71%
EBIT Next 5YN/A
FCF growth 1Y-85.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.67%
OCF growth 3YN/A
OCF growth 5YN/A

INSPIREMD INC / NSPR FAQ

What is the ChartMill fundamental rating of INSPIREMD INC (NSPR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NSPR.


Can you provide the valuation status for INSPIREMD INC?

ChartMill assigns a valuation rating of 0 / 10 to INSPIREMD INC (NSPR). This can be considered as Overvalued.


What is the profitability of NSPR stock?

INSPIREMD INC (NSPR) has a profitability rating of 0 / 10.


How financially healthy is INSPIREMD INC?

The financial health rating of INSPIREMD INC (NSPR) is 6 / 10.